Evidence map›Paper›PMID 38366610›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species.

Paa Kwesi Ankrah, Andrew Bock, Felicia Ruffin, Blake M Hanson, Cesar A Arias, Stacey A Maskarinec, Joshua Parsons, Vance G Fowler, Joshua T Thaden

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Paa Kwesi AnkrahDivision of Infectious Disease, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0009-0007-6991-8281
Andrew BockDuke University School of Medicine, Durham, North Carolina, USA.
Felicia RuffinDivision of Infectious Disease, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Blake M HansonCenter for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Cesar A AriasDepartment of Medicine, Weill Cornell Medical College, New York, New York, USA.
Stacey A MaskarinecDivision of Infectious Disease, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Joshua ParsonsDivision of Infectious Disease, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Vance G FowlerDivision of Infectious Disease, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Joshua T ThadenDivision of Infectious Disease, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Duke University · USHouston Methodist · USThe University of Texas Health Science Center at Houston · US

Funding

Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2020 to 2025
$12.0M
VENOUS: A translational study of enterococcal bacteremiaR01AI148342 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2020 to 2024
$3.9M
HLA Fine Mapping to Elucidate S. aureus SusceptibilityR01AI165671 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G., SCOTT, WILLIAM K · 2021 to 2025
$3.8M
The LiaFSR system and antimicrobial peptide resistance in enterococciR01AI134637 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Cesar Augusto Arias · 2018 to 2026
$3.7M
POR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5M
Staphylococcus aureus Cardiac Device Infections - From the Vascular ViewpointK23HL159275 · NHLBI · DUKE UNIVERSITY · PI Stacey A Maskarinec · 2022 to 2026
$897k
Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient MortalityK08AI171183 · NIAID · DUKE UNIVERSITY · PI Joshua T Thaden · 2022 to 2026
$895k
Mobile Genetic Elements and Clinical Outcomes in Staphylococcus aureus BacteremiaK01AI148593 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HANSON, BLAKE M · 2020 to 2023
$519k
National Institute of Allergy and Infectious DiseasesNHLBI NIH HHS K23 HL159275NIAID NIH HHS K01 AI148593NIAID NIH HHS K08 AI171183NIAID NIH HHS K24 AI121296NIAID NIH HHS P01 AI152999NIAID NIH HHS R01 AI134637NIAID NIH HHS R01 AI148342NIAID NIH HHS R01 AI165671NIH HHS 1R01AI165671
6 · The paper itself

Abstract

The association between persistent gram-negative bloodstream infection (GN-BSI), or ongoing positive cultures, and recurrent GN-BSI has not been investigated. Among 992 adults, persistent GN-BSI was associated with increased recurrent GN-BSI with the same bacterial species and strain (6% vs 2%; P = .04). Persistent GN-BSI may be a marker of complicated infection.

Indexed as

BacteremiaGram-Negative BacteriaGram-Negative Bacterial InfectionsRecurrenceAdultAgedFemaleHumansMaleMiddle AgedRisk Factorsbloodstream infectiongram-negativerecurrentreinfectionrelapse

Identifiers

PMID38366610
PMCPMC11175691
OpenAlexW4391898862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.